OAC
AZN icon

OMERS Administration Corp’s AstraZeneca AZN Stock Holding History

OMERS Administration Corp’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-826,368
Closed -$160M – 934
2026
Q1 		$160M Buy
+826,368
New +$159M 1.03% 25
2025
Q4 		– Sell
-3,800
Closed -$583K – 1078
2025
Q3 		$583K Buy
+3,800
New +$575K ﹤0.01% 695
2024
Q4 		– Sell
-3,200
Closed -$499K – 969
2024
Q3 		$499K Buy
+3,200
New +$517K ﹤0.01% 665

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OMERS Administration Corp's AZN Position: Q2 2026 in Review

OMERS Administration Corp sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 826,368 shares — an estimated $160M sold.

OMERS Administration Corp first reported a position in AZN in Q3 2024 and held it in 3 quarters. The position peaked at $160M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • OMERS Administration Corp reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 826,368 AstraZeneca shares in Q2 2026, an estimated $160M.
  • OMERS Administration Corp first reported a position in AstraZeneca in Q3 2024 and held it in 3 quarters.
  • OMERS Administration Corp's AstraZeneca position peaked at $160M in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.